|
Model Number SXPP1A301 |
Device Problems
Material Frayed (1262); Material Separation (1562)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 06/30/2023 |
Event Type
malfunction
|
Manufacturer Narrative
|
Product complaint(b)(4).Additional information: h6 component code: g07002 - device not returned.Additional information has been requested however not received.If further details are received at a later date a supplemental medwatch will be sent.Please clarify when the event occurred? 2.How the procedure was completed.3.Was there any adverse consequence associated with the patient? 4.Name of the procedure? 5.Please provide procedure date.6.Status of product return.The event displays lot: shmhla but the ip displays lot: shmbpb.Please advise which is the correct lot? a manufacturing record evaluation was performed for the finished device batch, and no non-conformances were identified.This is a combination product, and the event has been reviewed for both the suture and the triclosan.Trade name - irgacare®.Active ingredient(s) ¿ triclosan.Dosage form ¿ suture/solid/parenteral.Strength ¿ = 2360 g/m.This report is being submitted pursuant to the provisions of 21 cfr, part 803, part 4 subpart b.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
|
|
Event Description
|
It was reported a patient underwent a discectomy on (b)(6) 2023 and barbed suture was used.While closing the wound and the needle snapped from the suture.No adverse consequences were reported.Additional information has been requested.
|
|
Manufacturer Narrative
|
Product complaint # (b)(4).Date sent to the fda: 9/20/2023.This report is being submitted pursuant to the provisions of 21 cfr, part 803, part 4 subpart b.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Additional information was requested, the following was obtained: it did not break but started getting thinner and thinner, making surgeon afraid to use it.
|
|
Manufacturer Narrative
|
Product complaint # (b)(4).Additional information: d 9.Date device returned to manufacturer, d 9.Is device returned to manufacturer? additional information was requested, and the following was obtained: 1.Please clarify when the event occurred? (b)(6) 2023.2.Please provide procedure date? (b)(6) 2023.The following information was requested, but unavailable: 1.How the procedure was completed 2.Was there any adverse consequence associated with the patient? 3.Name of the procedure? attempts are being made to obtain the following information.To date no response has been provided.If further details are received at a later date a supplemental medwatch will be sent.Based on the previous response the correct lot for this event is from the event description, shmhla.However, samples from lot shmbpb were returned for evaluation.Please clarify if there was any quality issue with the sutures returned from lot shmbpb.Investigation summary: the product was returned to ethicon for evaluation.Visual inspection and functional testing were conducted on the returned device.The returned sample determined that seven unopened samples that pertain to the product code sxpp1a301 were received.In order to evaluate the condition of the returned samples, the packets were opened.The swage and attachment area was noted to be as expected.The sutures were dispensed without problems and examined along the strand no anomalies were observed during the evaluation.A functional test was performed using instron equipment and the pull force result was above the minimum requirements.As part of the ethicon quality process, all devices are manufactured, inspected, and released to approved specifications.A manufacturing record evaluation was performed for the finished device lot, and no non-conformances were identified.This report is being submitted pursuant to the provisions of 21 cfr, part 803, part 4 subpart b.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Corrected information: d 4.Lot, d 4.Expiration date, d 9.Device available for evaluation?, h3.Device evaluated by manufacturer?, h4.Device manufacture date, h6.Medical device problem code, h6.Component code, h6.Type of investigation, h6.Investigation findings, h6.Investigation conclusions.
|
|
Search Alerts/Recalls
|
|
|